The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of paraphilias

References

• AACAP Official Action. 1999. Practice parameters for the assessment and treatment of children and adolescents who are sexually abusive of others. J Am Acad Child Adolesc Psychiatry 38(S):12.
   Google Scholar
• Abel GG, Harlow N. 2001. The Abel and Harlow child molestation prevention sudy. The stop child molestation book. Philadelphia, PA: Xlibris.
   Google Scholar
• Abel GG, Becker JV, Cunningham-Rathner J, Mittelman M, Rouleau JL. 1988. Multiple diagnoses among sex offenders. Bull Am Acad Psychiatry Law 16(2):153–168.
   PubMedGoogle Scholar
• Abouesh A, Clayton A. 1999. Compulsive voyeurism and exhibitionism: a clinical response to paroxetine. Arch Sex Behav 28(1):23–30.
   PubMed Web of Science ®Google Scholar
• Adi Y, Ashcroft D, Browne K, Beech A, Fry-Smith A, Hyde C. 2002. Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sexual offenders. Health Technol Assess 6(28):1–67.
   PubMedGoogle Scholar
• Adshead G, Mezey G. 1993. Ethical issues in the psychotherapeutic treatment of paedophiles: whose side are you on? J Forensic Psychiatry 4(2):361–368.
   Google Scholar
• Alexander M, Gunn J, Cook DAG, Taylor PJ, Finch J. 1993. Should a sexual offender be allowed surgical castration? Br Med Journal 307:790–793.
   PubMed Web of Science ®Google Scholar
• Alexander MA. 1999. Sexual offender treatment efficacy revisited. Sexual Abuse: J Res Treat 11:101–116.
   PubMedGoogle Scholar
• Allolio B, Keffel , Deuss U, Winkelman W. 1985. Behandlung sexueller verhaltensstörungen mit LH-RH superagonisten. Dtsch Med Wochenscht 110:1952.
   PubMed Web of Science ®Google Scholar
• ATSA. 2004. Practice standards and guidelines for the evaluation, treatment and management of adult male sexual abusers [www.atsa.com].
   Google Scholar
• Bajos N, Bozon M, Beltzer N. 2008. Sexuality, prevention and gender relations during life. Med Sci S2:5–6.
   Google Scholar
• Baker M, White T. 2002. Sex offenders in high security care in Scotland. J Forensic Psychiatry 13:285–297.
   Web of Science ®Google Scholar
• Balon R. 1998. Pharmacological treatment of paraphilias with a focus on antidepressants. J Sex Marital Ther 24:241–254.
   PubMed Web of Science ®Google Scholar
• Balon R. 2000. Lithium for paraphilias? Probably not. J Sex Marital Ther 26(4):361–363.
   PubMed Web of Science ®Google Scholar
• Bancroft J, Tennent G, Loucas K, Cass J. 1974. The control of deviant sexual behaviour by drugs. I. Behavioural changes following estrogens and antiandrogens. Br J Psychiatry 125:310–315.
   PubMed Web of Science ®Google Scholar
• Banyard VL, Williams LM, Siegel JA. 2001. The long-term mental health consequences of child sexual abuse: an exploratory study of the impact of multiple traumas in a sample of women. J Trauma Stress 14(4):697–715.
   PubMed Web of Science ®Google Scholar
• Barbaree HE, Blanchard R, Langton CM. 2003. The development of sexual aggression through the life span: the effect of age on sexual arousal and recidivism among sex offenders. Ann NY Acad Sci 989:56–71.
   Web of Science ®Google Scholar
• Bartova D, Nahunek K, Svetka J. 1978. Pharamcological treatment of deviant sexual behavior. Act Nerv Super (Praha) 21:163–164.
   Google Scholar
• Bartholomew A. 1968. A long-acting phenothiazine as a possible agent to control deviant behaviour Am J Psychiatry 124: 917–923.
   PubMed Web of Science ®Google Scholar
• Beech A, Mitchell I. 2005. A neurobiological perspective on attachment problems in sexual offenders and the role of selective serotonin re-uptake inhibitors in the treatment of such problems. Clin Psychol Rev 25:153–182.
   PubMed Web of Science ®Google Scholar
• Beech A, Friendship C, Erikson M, Hanson RK. 2002. The relationship between static and dynamic risk factors and reconviction in a sample of UK child abusers. Sex Abuse J Res Treatment 14:155–168.
   PubMedGoogle Scholar
• Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. 1978. Hypophysal responses to continuous and intermittent delivery of hypothalamic gonadotrophin releasing hormone. Science 202:631–633.
   PubMed Web of Science ®Google Scholar
• Berlin F. 2003. Sex offender treatment and legislation. J Am Acad Psychiatry Law 31:510–513.
   PubMed Web of Science ®Google Scholar
• Berlin F. 2009. Commentary: Risk/benefit ratio of androgen deprivation treatment for sex offenders. J Am Acad Psychiatry Law 37:59–62.
   PubMed Web of Science ®Google Scholar
• Berlin FS, Coyle GS. 1981. Psychiatric clinics at the John Hopkins Hospital. Sexual deviation syndromes John Hopkins Med J 149:119–125.
   PubMedGoogle Scholar
• Berlin FS, Meinecke CF. 1981. Treatment of sex offenders with antiandrogenic medication: conceptualization, review of treatment modalities, and preliminary findings. Am J Psychiatry 138(5):601–607.
   PubMed Web of Science ®Google Scholar
• Bianchi MD. 1990. Fluoxetine treatment of exhibitionism. Am J Psychiatry 147(8):1089–1090.
   PubMed Web of Science ®Google Scholar
• Bladon E, Vizard E, French L. 2005. Young sexual abusers: a descriptive study of a UK sample of children showing sexually harmful behaviours. J Forensic Psychiatry Psychol 16:109–126.
   Web of Science ®Google Scholar
• Blanchard R, Christeasen BK, Strong SM. 2002. Retrospective self reports of childhood accidents causing unconsciousness in phallometrically diagnosed paedophiles. Arch Sex Behav 31:511–526.
   PubMed Web of Science ®Google Scholar
• Bourgeois JA, Klein M. 1996. Risperidone and fluoxetine in the treatment of paedophilia with comorbid dysthymia. J Clin Psychopharmacol 16:257–258.
   PubMed Web of Science ®Google Scholar
• Bourget D, Bradford JM. 1987. Fire fetishism, diagnostic and clinical implications: a review of two cases. Can J Psychiatry 32(6):459–462.
   PubMed Web of Science ®Google Scholar
• Bowden P. 1991. Treatment: use, abuse and consent. Criminal Behav Ment Health 1:130–141.
   Google Scholar
• Bradford J. 1996. The role of serotonin in the future of forensic psychiatry. Bull Am Acad Psychiatry Law 24:57–73.
   PubMedGoogle Scholar
• Bradford J, Fedoroff P. 2006. Pharmacological treatment of the juvenile sex offender. The juvenile sex offender. Barbaree H, Marshall W. 2nd. Chapter 16.New York: Guildford Press. 358–382.
   Google Scholar
• Bradford J, Greenberg D, Gojer J, Martindale J, Goldberg M. 1995. Sertraline in the treatment of pedophilia: an open label study. New Research Program Abstracts NR441, APA MTA, Florida.
   Google Scholar
• Bradford JM. 1993. The pharmacological treatment of the adolescent sex offender. Barbaree HE, Marshall WL, Hudson SM. The juvenile sex offender. New York: Guilford Press. 278–288.
   Google Scholar
• Bradford JM. 1999. The paraphilias, obsessive compulsive spectrum disorder, and the treatment of sexually deviant behaviour. Psychiatr Q 70(3):209–219.
   PubMed Web of Science ®Google Scholar
• Bradford JM. 2001. The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behavior. Can J Psychiatry 46(1):26–34.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Gratzer TG. 1995. A treatment for impulse control disorders and paraphilia: a case report. Can J Psychiatry 40(1):4–5.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Pawlak A. 1987. Sadistic homosexual pedophilia: treatment with cyproterone acetate: a single case study. Can J Psychiatry 32(1):22–30.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Pawlak A. 1993a. Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Arch Sex Behav 22(5):383–402.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Pawlak A. 1993b. Effects of cyproterone acetate on sexual arousal patterns of pedophiles. Arch Sex Behav 22(6): 629–641.
   PubMed Web of Science ®Google Scholar
• Bradford JM, Boulet J, Pawlak A. 1992. The paraphilias: a multiplicity of deviant behaviors. Can J Psychiatry 37:104–108.
   PubMed Web of Science ®Google Scholar
• Bradford JMW. 2000. The treatment of sexual deviations using a pharmacological approach. J Sex Res 37(3):248–257.
   Web of Science ®Google Scholar
• Bradford JMW, Greenberg DM. 1996. Pharmacological treatment of deviant sexual behavior. Annu Rev Sex Behav 7:283–306.
   Google Scholar
• Brahams D. 1988. Voluntary chemical castration of a mental patient. Lancet i(8597):1291–1292.
   Google Scholar
• Bremer J. 1959. Asexualization: a follow-up study of 244 cases. New York: MacMillan Co.
   Google Scholar
• Bremer JF. 1992. Serious juvenile sex offenders: treatment and long term follow-up. Psychiatr Ann 22:326–332.
   Web of Science ®Google Scholar
• Brière J, Runtz M. 1989. University males' sexual interest in children: predicting potential indices of “pedophilia” in a non-forensic sample. Child Abuse Negl 13(1):65–75.
   PubMed Web of Science ®Google Scholar
• Briken P. 2002. Pharmacotherapy of paraphilias with luteinizing hormone-releasing hormone agonists. Arch Gen Psychiatry 59:469–470.
   PubMed Web of Science ®Google Scholar
• Briken P, Nika E, Berner W. 2001. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists. J Sex Marital Ther 27(1):45–55.
   PubMed Web of Science ®Google Scholar
• Briken P, Hill A, Berner W. 2003. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review. J Clin Psychiatry 64(8):890–897.
   PubMed Web of Science ®Google Scholar
• Briken P, Hill A, Berner W. 2004. A relapse in pedophilic sex offending and subsequent suicide attempt during luteinizing hormone-releasing hormone treatment. J Clin Psychiatry 65(10):1429.
   PubMed Web of Science ®Google Scholar
• Briken P, Habermann N, Kafka MP, Berner W, Hill A. 2006. The paraphilia-related disorders: an investigation of the relevance of the concept in sexual murderers. J Forensic Sci 51(3):683–688.
   PubMed Web of Science ®Google Scholar
• Brooks-Gordon B, Bilby C, Wells H. 2006. A systematic review of psychological interventions for sexual offenders I. Randomised control trials. J Forensic Psychiatry 17(3):442–466.
   Google Scholar
• Byrne A, Brunet B, McGann P. 1992. Cyproterone acetate therapy and aggression. Br J Psychiatry 160:282–283.
   PubMed Web of Science ®Google Scholar
• Cantor JM, Kabani N, Christensen BK, Zipursky RB, Barbaree HE, Dickey R, . 2008. Cerebral white matter deficiencies in pedophilic men. J Psychiatr Res 42(3):163–183.
   PubMed Web of Science ®Google Scholar
• Carani C, Bancroft J, Granata A, Del Rio G, Marrama P. 1992. Testosterone and erectile function, nocturnal penile tumescence and rigidity, and erectile response to visual erotic stimuli in hypogonadal and eugonadal men. Psychoneuroendocrinology 17(6):647–654.
   PubMed Web of Science ®Google Scholar
• Cesnik JA, Coleman E. 1989. Use of lithium carbonate in the treatment of autoerotic asphyxia Am J Psychother 43 (2):277–286.
   PubMed Web of Science ®Google Scholar
• Chen KK, Chan SHH, Chang LS, Chan JY. 1997. Participation of paraventricular nucleus of hypothalamus in central regulation of penile erection in the rat. J Urol 158 (1):238–244.
   PubMed Web of Science ®Google Scholar
• Chow EW, Choy AL. 2002. Clinical characteristics and treatment response to SSRI in a female pedophile. Arch Sex Behav 31:211–215.
   PubMed Web of Science ®Google Scholar
• Cohen LJ, Galynker II. 2002. Clinical features of pedophilia and implications for treatment. J Psychiatr Pract 8:276–289.
   PubMedGoogle Scholar
• Cohen LJ, Nikiforov K, Gans S, Poznansky O, McGeoch P, Weaver C, . 2002. Heterosexual male perpetrators of childhood sexual abuse: a preliminary neuropsychiatric model. Psychiatr Q 73:313–336.
   PubMed Web of Science ®Google Scholar
• Cohen LJ, Frenda S, Mojtabai R, Katsavdakis K, Galynker I. 2007. Comparison of sexual offenders against children with sex offender registry. J Psychiatr Pract 13(6):373–384.
   PubMedGoogle Scholar
• Coleman E, Cesnik J, Moore AM, Dwyer SM. 1992. An exploratory study of the role of psychotropic medications in treatment of sexual offenders. J Off Rehab 18:75–88.
   Google Scholar
• Coleman E, Gratzer T, Nesvacil L Raymond NC. 2000. Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study. J Clin Psychiatry 61(4): 282–284
   PubMed Web of Science ®Google Scholar
• Cooper AJ. 1981. A placebo controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Compr Psychiatry 22(5):458–465.
   PubMed Web of Science ®Google Scholar
• Cooper AJ. 1986. Progestagens in the treatment of male sexual offenders: a review.
   Google Scholar
• Can J Psychiatry 31:73–79.
   Google Scholar
• Cooper AJ. 1987. Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia. J Clin Psychiatry 48(9):368–370.
   PubMed Web of Science ®Google Scholar
• Cooper AJ. 1988. Medroxyprogesterone acetate as a treatment for sexual acting out in organic brain syndrom Am J Psychiatry 145 (9):1179–1180.
   PubMed Web of Science ®Google Scholar
• Cooper AJ. 1995. Review of the role of two antilibidinal drugs in the treatment of sex offenders with mental retardation. Ment Retard 33(1): 42–48.
   PubMedGoogle Scholar
• Cooper AJ, Baxter D, Wong W, Losztyn S. 1987. Sadistic homosexual pedophilia treatment with cyproterone acetate. Can J Psychiatry. 32 (8):738–40.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Cernovsky Z. 1992. The effects of cyproterone acetate on sleeping and waking penile erections in pedophiles: possible implications for treatment. Can J Psychiatry 37(1):33–39.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Cernovski ZZ. 1994. Comparison of cyproterone acetate and leuprolide acetate (LHRH agonist) in a chronic pedophile: a clinical case study. Biol Psychiatry 36(4): 269–271.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Ismail AA, Phanjoo AL, Love DL. 1972. Antiandrogen (cyproterone acetate) therapy in deviant hypersexuality. Br J Psychiatry 120(554):59–63.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Losztyn S, Russell NC, Cernovsky Z. 1990. Medroxyprogesterone acetate, nocturnal penile tumescence, laboratory arousal, and sexual acting out in a male with schizophrenia. Arch Sex Behav 19(4):361–372.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Cernovsky Z, Magnus RV. 1992a. The long-term use of cyproterone acetate in pedophilia: a case study. J Sex Marital Ther 18(4):292–302.
   PubMed Web of Science ®Google Scholar
• Cooper AJ, Sandhu S, Losztyn S, Cernovsky Z. 1992b. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Can J Psychiatry 37(10): 687–693.
   PubMed Web of Science ®Google Scholar
• Cordoba OA, Chapel JL. 1983. Medroxyprogesterone acetate antiandrogen treatment of hypersexuality in a pedophiliac sex offender. Am J Psychiatry 140(8):1036–1039.
   PubMed Web of Science ®Google Scholar
• Cornu F. 1973. Catamnestic studies on castrated sex delinquents from a forensic psychiatric viewpoint. Basel: S. Karger.
   Google Scholar
• Coskun M, Mukaddes NM. 2008. Mirtazapine treatment in a subject with autistic disorder and fetischism. J Child Adolesc Psychopharmacol 18(2):206–209.
   PubMed Web of Science ®Google Scholar
• Council of Europe, Recommendation 2004. 10 concerning the protection of the human rights and dignity of persons with mental disorder, 2004.
   Google Scholar
• Craig LA, Browne KD, Stringer I, Hogwe TE. 2008. Sexual reconviction rates in the United Kingdom and actual risk estimates. Child Abuse Negl 32(1):121–138.
   PubMed Web of Science ®Google Scholar
• Creighton S. 2002. Recognising changes in incidence and prevalence. Browne K, Hanks H, Stratton P, Hamilton C. Early prediction and prevention of child abuse: a handbook. Chichester: J. Wiley and Sons.
   Google Scholar
• Czerny JP, Briken , Berner W. 2002. Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics. Eur Psychiatry 17(2):104–106.
   PubMed Web of Science ®Google Scholar
• Davies TS. 1974. Cyproterone acetate for male hypersexuality. J Int Med Res 2:159–163.
   PubMed Web of Science ®Google Scholar
• Dee Higley J, Mehlman PT, Polan RE. 1996. Testosterone and 5-HIAA correlate with different types of aggressive behaviors. Biol Psychiatry 40:1067–1082.
   PubMed Web of Science ®Google Scholar
• Dickey R. 1992. The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Can J Psychiatry 37:567–569.
   PubMed Web of Science ®Google Scholar
• Dickey R. 2002. Case report: the management of bone demineralization associated with long term treatment of multiple paraphilia with long acting LHRH agonists. J Sex Marital Ther 28:207–210.
   PubMed Web of Science ®Google Scholar
• Dickey R, Nussbaum D, Chevolleau K, Davidson H. 2002. Age as a differential characteristic of rapists, pedophiles, and sexual sadists. J Sex Marital Ther 28:211–218.
   PubMed Web of Science ®Google Scholar
• Dunsieth N, Nelson M, Brusman-Lovens L, Holcomb JL, Beckman D, Welge JA, . 2004. Psychiatric and legal features of 113 men convicted of sexual offenses. J Clin Psychiatry 65(3):293–300.
   PubMed Web of Science ®Google Scholar
• Eibl E. 1978. Treatment and after-care of 300 sex offenders, especially with regard to penile plethysmography. Justizministerium. Baden-Württemberg. Proceedings of the German Conference on treatment possibilities for sex offenders in Eppingen, Stuttgart.
   Google Scholar
• Elger BS. 2008. Research involving prisoners: consensus and controversies in international and European regulations. Bioethics 22:224–238.
   PubMed Web of Science ®Google Scholar
• Elliott M, Browne K, Kilcoyne J. 1995. Child sexual abuse prevention: what offenders tell us. Child Abuse Neglect 19(5):579–594.
   PubMed Web of Science ®Google Scholar
• Ellis H. 1933. Psychology of sex. London: William Heinemann.
   Google Scholar
• Emmanuel MP, Lydiard RB, Ballenger JC. 1991. Fluoxetine treatment of voyeurism. Am J Psychiatry 148:950.
   PubMed Web of Science ®Google Scholar
• Eriksson T, Eriksson M. 1998. Irradiation therapy prevents gynecomastia in sex offenders treated with antiandrogens. J Clin Psychiatry 59(8):432–433.
   PubMed Web of Science ®Google Scholar
• Fedoroff J. 1995. Antiandrogens versus serotoninergic medications in the treatment of sex offenders: a preliminary compliance study. Can J Hum Sexuality 4:111–123.
   Google Scholar
• Fedoroff JP. 1992. Buspirone hydrochloride in the treatment of an atypical paraphilia Arch Sex Behav 21 (4):401–406.
   PubMed Web of Science ®Google Scholar
• Fenichel O. 1954. The Psychology of transvestism “collected papers”. London: Routledge and Kegan Paul.
   Google Scholar
• Field. 1973. The treatment of sexual offenders. Med Sci Law 13:195–196.
   PubMed Web of Science ®Google Scholar
• Fong TW, De la Garza RH, Newton TF. 2005. A case report of topiramate in the treatment of nonparaphilic sexual addiction. J Clin Psychopharmacol 25:512–514.
   PubMed Web of Science ®Google Scholar
• Foote R. 1944. Hormone treatment of sex offenders. J Nerv Ment Dis 99:928–929.
   Google Scholar
• Freud S. 1905/1953. Three essays on the theory of sexuality. In: Complete psychological works of Sigmund Freud. Standard. Vol. 7. London: Hogarth Press.
   Google Scholar
• Gaffney GR, Berlin FS. 1984. Is there hypothalamic-pituitary-gonadal dysfunction in paedophilia? Br J Psychiatry 145:657–660.
   PubMed Web of Science ®Google Scholar
• Gagné P. 1981. Treatment of sex offenders with medroxyprogesterone acetate. Am J Psychiatry 138(5):644–646.
   PubMed Web of Science ®Google Scholar
• Gallagher CA, Wilson DB, Hirschfield P, Coggeshall MB, MacKenzie DL. 1999. A quantitative review of the effects of sex offender treatment on sexual reoffending. Corrections Management Q 3:19–29.
   Google Scholar
• Galli V, McElroy S, Soutullo C, Kûzer D, Raute N, Keck PE Jr, McConville BJ. 1999. The psychiatric diagnoses of twenty-two adolescents who have sexually molested other children. Compr Psychiatry 40(2):85–88.
   PubMed Web of Science ®Google Scholar
• Gerardin P, Thibaut F. 2004. Epidemiology and treatment of juvenile sexual offending. Paediatr Drugs 6(2):79–91.
   PubMedGoogle Scholar
• Gijs L, Gooren L. 1996. Hormonal and psychopharmacological interventions in the treatment of paraphilias: an update. J Sex Res 33(4):273–290.
   Web of Science ®Google Scholar
• Giltay EJ, Gooren LJG. 2009. Potential side effects of androgen deprivation treatment in sex offenders. J Am Acad Psychiatry Law 37:53–58.
   PubMed Web of Science ®Google Scholar
• Goldman Juliette DG, Padayachi UK. 2000. Some methodological problems in estimating incidence and prevalence in child sexual abuse research. J Sex Res 37(4):305–314.
   Web of Science ®Google Scholar
• Golla FL, Hodge SR. 1949. Hormone treatment of sexual offenders. Lancet i(6563):1006–1007.
   Google Scholar
• Gooren LJ, Lips P, Gijs L. 2001. Osteoporosis and androgen-depleting drugs in sex offenders. Lancet 357(9263):1208–1209.
   PubMed Web of Science ®Google Scholar
• Gordon H. 2008. The treatment of paraphilias. An historical perspective (editorial). Criminal Behav Ment Health 18:79–87.
   PubMedGoogle Scholar
• Gordon H, Grubin D. 2004. Psychiatric aspects of the assessment and treatment of sex offenders. Adv Psychiatr Treat 10:73–80.
   Google Scholar
• Gottesman HG, Schubert DS. 1993. Low-dose oral medroxyprogesterone acetate in the management of the paraphilias. J Clin Psychiatry 54(5):182–188.
   PubMed Web of Science ®Google Scholar
• Grasswick LJ, Bradford JM. 2003. Osteoporosis associated with the treatment of paraphilias: A clinical review of seven case reports. J Forensic Sci 48:849–855.
   PubMed Web of Science ®Google Scholar
• Greenberg DM. 1998. Sexual recidivism in sex offenders. Can J Psychiatry 43(5):459–465.
   PubMed Web of Science ®Google Scholar
• Greenberg DM, Bradford JMW. 1997. Treatment of the paraphilic disorders: a review of the role of the selective serotonin reuptake inhibitors. Sex Abuse: J Res Treat 9(4):349–360.
   Google Scholar
• Greenberg DM, Bradford JMW, Curry S, O'Rourke A. 1996. A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: a retrospective study. Bull Am Acad Psychiatry Law 24(4):525–532.
   PubMedGoogle Scholar
• Grinshpoon A, Levy A, Rapoport A, Rabinowitz S. 1991. Cyproterone acetate treatment and sexual dysinhibition. Med Law 10(6):609–613.
   PubMedGoogle Scholar
• Grossmann LS, Martis B, Fichter CG. 1999. Are sex offenders treatable? A research overview. Psychiatr Serv 50:349–391.
   PubMed Web of Science ®Google Scholar
• Group for the Advancement of Psychiatry. 2000. Homosexuality and the mental health professions: the impact of bias. London: Analytic Press.
   Google Scholar
• Guay D. 2008. Inappropriate sexual behaviors in cognitively impaired older individuals. Am J Ger Pharmacother 6(5): 269–288.
   PubMedGoogle Scholar
• Guay DRP. 2009. Drug treatment of paraphilic and non-paraphilic sexual disorders. Clin Ther 31(1):1–31.
   PubMed Web of Science ®Google Scholar
• Hall GC. 1995. Sexual offender recidivism revisited: a meta-analysis of recent treatment studies. J Consult Clin Psychol 63(5):802–809.
   PubMed Web of Science ®Google Scholar
• Hall RC, Hall RCW. 2007. A profile of pedophilia: definition, characteristics of offenders, recidivism, treatment outcomes, and forensic issues. Mayo Clin Proc 82(4):457–471.
   PubMed Web of Science ®Google Scholar
• Hansen H, Lykke-Olesen L. 1997. Treatment of dangerous sexual offenders in Denmark. J Forensic Psychiatry 8:195–199.
   Web of Science ®Google Scholar
• Hanson RK, Bussiere MT. 1998. Predicting relapse: a meta-analysis of sexual offender recidivism studies. J Consult Clin Psychol 66(2):348–362.
   PubMed Web of Science ®Google Scholar
• Hanson RK, Morton-Bourgon KE. 2005. The characteristics of persistent sexual offenders: a meta-analysis of recidivism studies. J Consult Clin Psychol 73(6):1154–1163.
   PubMed Web of Science ®Google Scholar
• Hanson RK, Gordon A, Harris AJ, Marques JK, Murphy W, Quinsey VL, Seto MC. 2002. First report of the collaborative outcome data project on the effectiveness of psychological treatment for sex offenders. Sex Abuse 14(2):169–194, discussion 195–197.
   PubMedGoogle Scholar
• Hanson RK, Morton KE, Harris AJ. 2003. Sexual offender recidivism risk: what we know and what we need to know. Ann NY Acad Sci 989:154–166, discussion 236–246.
   PubMed Web of Science ®Google Scholar
• Harris AJR, Hanson RK. 2004. La récidive sexuelle: d’une simplicité trompeuse. Ottawa: Sécurité publique et Protection Civile Canada.
   Google Scholar
• Harris J, Grace SA. 1999. A question of evidence? Investigating and prosecuting rape in the 1990s. London: The Stationery Office Limited
   Google Scholar
• Heim N. 1981. Sexual behaviour of castrated sex offenders. Arch Sex Behav 10:11–19.
   PubMed Web of Science ®Google Scholar
• Heim N, Hursch CJ. 1979. Castration for sex offenders: treatment or punishment? A review and critique of recent European literature. Arch Sex Behav 8:281–304.
   PubMed Web of Science ®Google Scholar
• Heinemann LA, Will-Shahab L, Van Kesteren P. 1997. Safety of cyproterone acetate: report of active surveillance. Pharmacoepidemiol Drug Saf 6:169–178.
   PubMed Web of Science ®Google Scholar
• Heller CG, Laidlaw WM, Harvey HT. 1958. Effects of progestational compounds on the reproductive process of the human male. Ann NY Acad Sci 71:649–655.
   PubMed Web of Science ®Google Scholar
• Hill A, Briken P, Kraus C, Strohm K, Berner W. 2003. Differential pharmacological treatment of paraphilias and sex offenders. Int J Offender Ther Comp Criminol 47(4): 407–421.
   PubMed Web of Science ®Google Scholar
• Hill D, Pond DA, Mitchell W, Falconer MA. 1957. Personality changes following temporal lobectomy for epilepsy. J Ment Sci 103:18–27.
   PubMed Web of Science ®Google Scholar
• Hirschfield M. 1948. Sexual anomalies and perversions. London: Francis Alder.
   Google Scholar
• Home Office. 1997. Statistics of mentally disordered offenders in England and Wales 1996. Home Office Statistical Bulletin, 20/97. London: Home Office.
   Google Scholar
• Hoogeveen GH, Van Der Veer E. 2008. Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia. J Sex Med 5(3):626–630.
   PubMed Web of Science ®Google Scholar
• Hucker S, Langevin R, Wirtzman G, Bain J, Handy L, Chambers J, Wright S. 1986. Neuropsychological impairment in pedophiles. Sex Abuse 18:440–448.
   Google Scholar
• Hucker S, Langevin R, Bain J. 1988. A double-blind trial of sex drive reducing medication in pedophiles. Ann Sex Res 1:27–247.
   Google Scholar
• Hughes JR. 2007. Review of medical reports on pedophilia. Clin Pediatr 46(8):667–682.
   PubMed Web of Science ®Google Scholar
• Jacobsen FM. 1992. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 53: 119–122.
   PubMed Web of Science ®Google Scholar
• Jeffcoate WJ, Matthews RW, Edwards CR, Field LH, Besser GM. 1980. The effect of cyproterone acetate on serum testosterone, LH, FSH and prolactin in male sexual offenders. Clin Endocrinol 13(2):189–195.
   PubMed Web of Science ®Google Scholar
• Johnstone T. 1913. Lectures on Clinical Psychiatry by Dr Emil Kraeplin. 3rd. London: Bailliere, Tindall and Cox.
   Google Scholar
• Khazaal Y, Zullino DF. 2006. Topiramate in the treatment of compulsive sexual behavior: case report. BMC Psychiatry 6:22.
   PubMed Web of Science ®Google Scholar
• Kadar T, Telegdy G, Schally AV. 1992. Behavioral effects of centrally administered LH-RH agonist in rats. Physiol Behav 50:601–605.
   Web of Science ®Google Scholar
• Kafka MP. 1991. Successful treatment of paraphilic coercive disorder (a rapist) with fluoxetine hydrochloride. Br J Psychiatry 158:844–847.
   PubMed Web of Science ®Google Scholar
• Kafka MP. 1994. Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiatry 6(3):189–195.
   PubMedGoogle Scholar
• Kafka MP. 2003. The monoamine hypothesis for the pathophysiology of paraphilic disorders: an update. Ann NY Acad Sci 989:86–94.
   PubMed Web of Science ®Google Scholar
• Kafka MP, Coleman E. 1991. Serotonin and paraphilias: the convergence of mood, impulse and compulsive disorders. J Clin Psychopharmacol 11(3):223–224.
   PubMed Web of Science ®Google Scholar
• Kafka MP, Hennen J. 2000. Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: a case series. J Clin Psychiatry 61(9):664–670.
   PubMed Web of Science ®Google Scholar
• Kafka MP, Hennen J. 2002. A DSM-IV Axis I comorbidity study of males (n=120) with paraphilias and paraphilia-related disorders. Sex Abuse 14(4):349–366.
   PubMedGoogle Scholar
• Kafka MP, Prentky R. 1992a. A comparative study of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiatry 53:345–350.
   PubMed Web of Science ®Google Scholar
• Kafka MP, Prentky R. 1992b. Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiatry 53(10):351–358.
   PubMed Web of Science ®Google Scholar
• Kafka MP, Prentky R. 1998. Attention-deficit/hyperactivity disorder in males with paraphilias and paraphilia-related disorders: a comorbidity study. J Clin Psychiatry 59(7):388–396.
   PubMed Web of Science ®Google Scholar
• Kahn TJ, Lafond MA. 1988. Treatment of the adolescent sexual offender. Child Adolesc Social Work J 5:135–148.
   Google Scholar
• Kasper P. 2001. Cyproterone acetate: a genotoxic carcinogen? Pharmacol Toxicol 88(5):223–231.
   PubMedGoogle Scholar
• Kavousi RJ, Kaplan M, Becker JV. 1988. Psychiatric diagnoses in adolescent sex offenders. J Am Acad Child Adolesc Psychiatry 27(2):241–243.
   PubMed Web of Science ®Google Scholar
• Kendrick KM, Dixson AF. 1985. Luteinizing hormone releasing hormone enhances proceptivity in a primate. Neuroendocrinology 41:449–453.
   PubMed Web of Science ®Google Scholar
• Kenworthy T, Adams CE, Bilby C, Brooks-Gordon B, Fenton M. 2004. Psychological interventions for those who have sexually offended or are at risk of offending. Cochrane Database Syst Rev 3:CD 004858.
   Google Scholar
• Kernberg OF. 1991. Sadomasochism, sexual excitement, and perversion; J Am Psychol Assoc 39:333–362.
   PubMed Web of Science ®Google Scholar
• Kiersch TA. 1990. Treatment of sex offenders with Depo Provera. Bull Am Acad Psychiatry Law 18:179–187.
   PubMedGoogle Scholar
• King M, Bartlett A. 1999. British psychiatry and homosexuality. Br J Psychiatry 175:106–113.
   PubMed Web of Science ®Google Scholar
• Krafft-Ebing R von. 1886/1965. Psychopathia sexualis. Klaf FS. London: Staples Press.
   Google Scholar
• Kraus C, Hill A, Haberman N, Strohm K, Berner W, Briken P. 2006. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of paraphilia. A retrospective study. Forstchr Neurol Psychiatry 74:1–6.
   Google Scholar
• Kravitz HM, Haywood TW, Kelly J, Wahlstrom C, Liles S, Cavanaugh JL Jr. 1995. Medroxyprogesterone treatment for paraphiliacs. Bull Am Acad Psychiatry Law 23(1):19–33.
   PubMedGoogle Scholar
• Kravitz HM, Haywood TW, Kelly J, Liles S, Cavanaugh JL Jr. 1996. Medroxyprogesterone and paraphiles: do testosterone levels matter? Bull Am Acad Psychiatry Law 24(1):73–83.
   PubMedGoogle Scholar
• Krueger RB, Kaplan MS. 2000. Disorders of sexual impulse control in neuropsychiatric conditions. Semin Clin Neuropsychiatry 5(4):266–274.
   PubMedGoogle Scholar
• Krueger RB, Kaplan MS. 2001. Depot-leuprolide acetate for treatment of paraphilias: a report of twelve cases. Arch Sex Behav 30(4):409–422.
   PubMed Web of Science ®Google Scholar
• Krueger RB, Hembree W, Hill M. 2006. Prescription of medroxyprogesterone acetate to a patient with pedophilia, resulting in Cushing's syndrome and adrenal insufficiency. Sex Abuse 18(2):227–228.
   PubMed Web of Science ®Google Scholar
• Kruesi M, Fine S, Valladares L, Phillips RA, Rapoport J. 1992. Paraphilias: a double-blind cross-over comparison of clomipramine versus desipramine. Arch Sex Behav 21(6): 587–593.
   PubMed Web of Science ®Google Scholar
• Langeluddeke A. 1963. Castration of sexual criminals (German). Berlin: De Gruyter.
   Google Scholar
• Langevin R. 2006. Sexual offenses and traumatic brain injury. Brain Cogn 60(2):206–207.
   PubMed Web of Science ®Google Scholar
• Langevin R, Paitich D, Hucker S, Newman S, Ramsey G, Pope S, . 1979. The effect of assertiveness training, Provera and sex of therapist in the treatment of genital exhibitionnism. J Behav Ther Exp Psychiatry 10:275–282.
   Web of Science ®Google Scholar
• Langevin R, Wortzman G, Wright P, Handy L. 1989. Studies of brain damage and dysfunction in sex offenders. Sex Abuse 2:163–179.
   Google Scholar
• Laron Z, Kauli R. 2000. Experience with the cyproterone acetate in the treatment of precocious puberty. J Pediatr Endocrinol Metab 13(S1):805–810.
   PubMedGoogle Scholar
• Lashet U, Lashet L. 1967. Antiandrogen treatment of pathologically increased and abnormal sexuality in men. Klein Wochenschr 45(6):324–325.
   PubMedGoogle Scholar
• Lashet U, Lashet L. 1971. Psychopharmacotherapy of sex offenders with cyproterone acetate. Pharmacopsychiatr Neuropsychopharmacol Adv Clin Res 4(2):99–110.
   Google Scholar
• Laschet U, Laschet L. 1975. Antiandrogens in the treatment of sexual deviations of men. J Steroid Biochem 6:821–826.
   PubMedGoogle Scholar
• Laws DR, O'Donohue W. 1997. Introduction: fundamental issues in sexual deviance. Laws DR, O'Donohue W. Sexual deviance: Theory, assessment and treatment. London: Guilford Press. 1–21.
   Google Scholar
• Lederer J. 1974. Treatment of sex deviations with cyproterone acetate. Probl Actuels Endocrinol Nutr 18:249–260.
   PubMedGoogle Scholar
• Lehne GK. 1984. Brain damage and paraphilia treated with medroxyprogesterone acetate. Sex Disabil X:145–158.
   Google Scholar
• Leo RJ, Kim KY. 1995. Clomipramine treatment of paraphilias in elderly demented patients. J Geriatr Psychiatry Neurol 8(2): 123–124.
   PubMed Web of Science ®Google Scholar
• Leonard LM, Follette VM. 2002. Sexual functioning in women reporting a history of child sexual abuse: review of the empirical literature and clinical implications. Annu Rev Sex Res 13:346–388.
   PubMedGoogle Scholar
• Light SA, Holroyd S. 2006. The use of medroxyprogesterone acetate for the treatment of sexually inappropriate behaviour in patients with dementia. J Psychiatry Neurosci 31(0002):132–134.
   PubMedGoogle Scholar
• Loosen PT, Purdon SE, Pavlou SN. 1994. Effects on behavior of modulation of gonadal function in men with gonadotrophin-releasing hormone antagonists. Am J Psychiatry 151:271–273.
   PubMed Web of Science ®Google Scholar
• Lorefice LS. 1991. Fluoxetine treatment of a fetishist. J Clin Psychiatry 52(1):41.
   PubMed Web of Science ®Google Scholar
• Lorrain DS, Riolo JV, Matuszewich L, Hull EM. 1999. Lateral hypothalamic serotonin inhibits nucleus accumbens dopamine: implications for sexual satiety. J Neurosci 19(17):7648–7652.
   PubMed Web of Science ®Google Scholar
• Losel F, Schmucker M. 2005. The effectiveness of treatment for sexual offenders: a comprehensive meta-analysis. J Exp Criminol 1(1):117–146.
   Google Scholar
• Maes M, De Vos N, Van Hunsel F, Van West D, Westenberg H, Cosyns P, Neels H. 2001. Pedophilia is accompagnied by increased plasma concentrations of catecholamines, in particular epinephrine. Psychiatry Res 103(1):43–49.
   PubMed Web of Science ®Google Scholar
• Maletzki BM, Steinhauser C. 2002. A 25-year follow-up of cognitive-behavioral therapy with 7275 sexual offenders. Behav Modif 26:123–147.
   PubMed Web of Science ®Google Scholar
• Maletzky BM, Tolan A, McFarland B. 2006. The Oregon depo-Provera program: a five-year follow-up. Sex Abuse 18(3):206–316.
   Web of Science ®Google Scholar
• Malin HM, Saleh FM. 2007. Paraphilias: clinical and forensic considerations. Psychiatric Times 24(5):1–4.
   Google Scholar
• Marques JK, Day DM, Nelson C, West MA. 1994. Effects of cognitive-behavioural treatment on sex offender recidivism. Criminal Justice Behav 21:28–54.
   Web of Science ®Google Scholar
• Marques JK, Wiederanders M, Day DM, Nelson C, Van Ommeren A. 2005. Effects of a relapse prevention program on sexual recidivism: final results from California's sex offender treatment and evaluation project (SOTEP). Sex Abuse 17(1):79–107.
   PubMed Web of Science ®Google Scholar
• Marshall P. 1997. The prevalence of convictions for sexual offending. Home Office research and statistics directorale research findings. 55th. London: Home Office.
   Google Scholar
• Marshall WL. 2006. Diagnostic problems with sexual offenders Marshall WL, Fernandez YM, Marshall LE, Serran GA. Sexual offender treatment: controversial issues. Chichester: Wiley. 33–43.
   Google Scholar
• Marshall WL, Barbaree HE. 1990. Outcome of comprehensive cognitive-behavioural treatment programs. Marshall WL, Laws DR, Barbaree HE. Handbook of sexual assault: issues, theories and treatment of the offenders. New York: Plenum Press. 363–385.
   Google Scholar
• Marshall WL, Fernandez YM. 2000. Phallometric testing with sexual offenders: limits to its value. Clin Psychol Rev 20(7):807–822.
   PubMed Web of Science ®Google Scholar
• Marshall WL, Marshall LE. 2007. The utility of the random controlled trial for evaluating sexual offender treatment: the gold standard or an inappropriate strategy? Sex Abuse 19: 175–191.
   PubMed Web of Science ®Google Scholar
• Marshall WL, Ward T, Mann RE, Moulden H, Fernandez YM, Serran G, Marshall LE. 2005. Working positively with sexual offenders: maximizing the effectiveness of treatment. J Interpers Violence 20(9):1096–1114.
   PubMed Web of Science ®Google Scholar
• McConaghy N. 1998. Paedophilia: a review of the evidence. Aust NZ J Psychiatry 32:252–265.
   PubMed Web of Science ®Google Scholar
• McConaghy N, Blaszczynski A, Armstrong MS. 1989. Resistance to treatment of adolescent sex offenders. Arch Sex Behav 18:97–107.
   PubMed Web of Science ®Google Scholar
• McEvoy G. 1999. AHFS drug information. Bethesda, MD: American Society of Health System Pharmacists.
   Google Scholar
• McKenna K. 1999. The brain is the master organ in sexual function. CNS control of male and female sexual function. Int J Impot Res 11(S1):48–55.
   Google Scholar
• Meisell RL, Sachs BD. 1994. The physiology of male sexual behavior. Knobil E, Neill JD. The physiology of reproduction. New York: Raven Press. 3–105.
   Google Scholar
• Melior CS, Farid NR, Craig DF. 1988. Female hypersexuality treated with cyproterone acetate. Am J Psychiatry 145:1037.
   Web of Science ®Google Scholar
• Mellela JT, Travin S, Cullen K. 1989. Legal and ethical issues in the use of antiandrogens in treating sex offenders. Bull Am Acad Psychiatr Law 17(3):223–232.
   PubMedGoogle Scholar
• Mendez MF, Chow T, Ringman J, Twitchell G, Hinkin CH. 2000. Pedophilia and temporal disturbances. J Neuropsychiatry Clin Neurosci 12:71–76.
   PubMed Web of Science ®Google Scholar
• Meston CM, Frohlich PF. 2000. The neurobiology of sexual function. Arch Gen Psychiatry 57:1012–1030.
   PubMed Web of Science ®Google Scholar
• Meyer JW, Cole CM. 1997. Physical and chemical castration of sex offenders: a review. J Off Rehab 25(3–4):1–18.
   Google Scholar
• Meyer WJ, Walker PA, Emory LE, Smith ER. 1985. Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogeterone acetate. Fertil Steril 43(1):102–109.
   PubMed Web of Science ®Google Scholar
• Meyer WJ, Cole CM, Emory E. 1992a. Depo provera treatment of sex offending behavior: an evaluation of outcome. Bull Am Acad Psychiatry Law 20(3):249–259.
   PubMedGoogle Scholar
• Meyer WJ, Wiener I, Emory LE, Cole CM, Isenberg N, Fagan CJ, Thompson JC. 1992b. Cholelithiasis associated with medroxyprogesterone acetate in therapy with men. Res Commun Chem Pathol Pharmacol 75(1):69–84.
   PubMedGoogle Scholar
• Mitchell W, Falconer MA, Hill D. 1954. Epilepsy with fetishism relieved by temporal lobectomy. Lancet ii:626–630.
   Google Scholar
• Money J. 1968. Discussion on hormonal inhibition of libido in male sex offenders. Michael RP. Endocrinology and human behaviour. London: Oxford University Press. 169.
   Google Scholar
• Money J, Wiedeking C, Walker P, Migeon C, Meyer W, Borgaonkar D. 1975. 47, XYY and 46, XY males with antisocial and/or sex offending behavior: antiandrogen therapy plus counselling. Psychoneuroendocrinology 1:165–178.
   PubMed Web of Science ®Google Scholar
• Money J, Bennett RG, Cameron WR. 1981. Postadolescent paraphiliac sex offenders: hormonal and counseling therapy follow-up. Int J Ment Health. 6:25–45.
   Google Scholar
• Morrison T, Erooga M, Beckett RL. 1994. Adult sex offenders: who are they? Why and how do they do it? Sexual offending against children: assessment and treatment of male abusers. London: Routledge. 1–24.
   Google Scholar
• Moss RL, Dudley CA. 1989. Luteinizing hormone releasing hormone (LHRH) peptidergic signals in the neural integration of female reproductive behavior. Lakoski JM, Perez-Polo JR, Rassin DK. Neural control of reproductive function. New York: Liss. 485–499.
   Google Scholar
• Mothes B, Lehnert J, Samimi , Ufer J. 1971. Klinishe Prüfung von cyproteronacetat bei sexualdeviationen gesamtauswertung. Raspe G. Schering symposium über sexualdeviationen und ihre medikamentöse behandlung. Berlin Live Sci Monogr 2:65–87.
   Google Scholar
• Murray MA, Bancroft JH, Anderson DC, Tennent TG, Carr PJ. 1975. Endocrine changes in male sexual deviants after treatment with anti-androgens, oestrogens or tranquillizers. J Endocrinol 67(2):179–188.
   PubMed Web of Science ®Google Scholar
• Nelson E, Brusman L, Holcomb J, Soutello C, Beckman D, Welge JA, . 2001. Divalproex sodium in sex offenders with bipolar disorders and comorbid paraphililas: an open retrospective study. J Affect Disord 64(2–3):249–255.
   PubMed Web of Science ®Google Scholar
• Neuman F. 1977. Pharmacology and potential use of cyproterone acetate. Horm Metab Res 9:1–13.
   PubMed Web of Science ®Google Scholar
• Neuman F, Thiereau D, Andrea U, Greim H, Schwarz LR. 1992. Cyproterone acetate induces DNA damage in cultured rat hepatocytes and preferentially stimulates DNA synthesis in gamma-glutamyltranspeptidase-positive cells. Carcinogenesis 13:373–378.
   PubMed Web of Science ®Google Scholar
• Ortmann J. 1980. The treatment of sexual offenders: castration and antihormone therapy. Int J Law Psychiatry 3:443–451.
   PubMed Web of Science ®Google Scholar
• Ott BR. 1995. Leuprolide treatment of sexual aggression in a patient with dementia and the Klüver-Bucy syndrome. Clin Neuropharmacol 18(5):443–447.
   PubMed Web of Science ®Google Scholar
• Pearson HJ. 1990. Paraphilias, impulse control and serotonin. J Clin Psychopharmacol 10:133–134.
   PubMed Web of Science ®Google Scholar
• Perilstein R, Lipper S, Friedman LJ. 1991. Three cases of paraphilias responsive to fluoxetine treatment. J Clin Psychiatry 52(4):169–170.
   PubMed Web of Science ®Google Scholar
• Pithers WD, Becker JV, Kafka M, Morentz B, Schalnk A, Leombruno T. 1995. Children with sexual behavior problems, adolescent sexual abusers and adult sex offenders: assessment and treatment. Int Rev Psychiatry 14:779–818.
   Google Scholar
• Prentky RA, Lee AFS, Knight RA, Cerce D. 1997. Recidivism rates among child molesters and rapists: a methodological analysis. Law Hum Behav 21(6):635–659.
   PubMed Web of Science ®Google Scholar
• Raymond N, Coleman E, Ohlerking F. 1999. Psychiatric comorbidity in pedophilic sex offenders. Am J Psychiatry 156:786–788.
   PubMed Web of Science ®Google Scholar
• Reilly DR, Delva NJ, Hudson RW. 2000. Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia. Can J Psychiatry 45:559–563.
   PubMed Web of Science ®Google Scholar
• Reitzel LR, Carbonell JL. 2006. The effectiveness of sexual offender treatment for juveniles as measured by recidivism: a meta-analysis. Sex Abuse 18(4):401–421.
   PubMed Web of Science ®Google Scholar
• Rich SS, Osview F. 1994. Leuprolide acetate for exhibitionism in Huntington's disease.Mov Disord 9 (3):353–357.
   PubMed Web of Science ®Google Scholar
• Roeder FD. 1966. Stereotaxic lesion of the tuber cinerium in sexual deviation. Confinia Neurol 27:162–163.
   PubMedGoogle Scholar
• Roeder FD, Orthner H, Muller D. 1972. The stereotaxic treatment of paedophilic homosexuality and other sexual deviations. Hitchcock L, Laitinen L, Vaernet K. Psychosurgery. Springfield, IL: Thomas. 87–111.
   Google Scholar
• Romero JJ, Williams LM. 1983. Group psychotherapy and intensive probation supervision with sex offenders. Federal Probation 47:36–42.
   Google Scholar
• Rosen I. 1997. Sexual deviation. 3rd. Oxford: Oxford University Press.
   Google Scholar
• Rösler A, Witztum E. 1998. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. New Engl J Med 338:416–422.
   PubMed Web of Science ®Google Scholar
• Rosler A, Witztum E. 2000. Pharmacotherapy of paraphilias in the next millennium. Behav Sci Law 18(1):43–56.
   PubMed Web of Science ®Google Scholar
• Ross LA, Bland WP, Ruskin P, Bacher N. 1987. Antiandrogen treatment of aberrant sexual activity. Am J Psychiatry 144(11):1511.
   PubMed Web of Science ®Google Scholar
• Rousseau L, Couture M, Dupont A, Labrie F, Couture N. 1990. Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism. Can J Psychiatry 35:338–341.
   PubMed Web of Science ®Google Scholar
• Rubinow DR, Schmidt PJ. 1996. Androgens, brain and behavior. Am J Psychiatry 153:974–984.
   PubMed Web of Science ®Google Scholar
• Ruby R, Brady KT, Norris GT. 1993. Clomipramine treatment of sexual preoccupation. J Clin Pharmacol 13:158–159.
   Google Scholar
• Ryback RS. 2004. Naltrexone in the treatment of adolescent sexual offenders. J Clin Psychiatry 65(7):982–986.
   PubMed Web of Science ®Google Scholar
• Saleh F. 2005. A hypersexual paraphilic patient treated with leuprolide acetate: a single case report. J Sex Marital Ther 31(5): 433–444.
   PubMed Web of Science ®Google Scholar
• Saleh FM.2004. Serotonin reuptake inhibitors and the paraphilias. Am Acad Psychiatry Law Newsletter 12–13.
   Google Scholar
• Saleh FM, Niel T, Fishman MJ. 2004. Treatment of paraphilia in young adults with leuprolide acetate: a preliminary case report series. J Forensic Sci 49(6):1343–1348.
   PubMed Web of Science ®Google Scholar
• Sammet K. 2005. Risking more freedom? Cyproterone acetate, sexual offenders and the German “Law on voluntary castration and other methods of treatment” 1960–1975. Medizinhist J 40(1):51–78.
   PubMedGoogle Scholar
• Sanderson R. 1960. Clinical trial with Melleril in the treatment of schizophrenia. J Ment Sci 106:732–741.
   PubMed Web of Science ®Google Scholar
• Schiffer B, Peschel T, Paul T Gizewski E, Forsting M, Leygraf N, . 2007. Structural brain abnormalities in the frontostriatal system and cerebellum in pedophilia. J Psychiatr Res 41(9): 753–762.
   PubMed Web of Science ®Google Scholar
• Schiltz K, Witzel J, Northoff G, Zierhut K, Gubka U, Fellmann H, . 2007. Brain pathology in pedophilic offenders. Arch Gen Psychiatry 64:737–746.
   PubMed Web of Science ®Google Scholar
• Schlesinger LB.2004. Sexual murder: catathymic and compulsive homicides. London: CRC Press.
   Google Scholar
• Schober JM, Kuhn PJ, Kovacs PG, Earle JH, Byrne PM, Fries RA. 2005. Leuprolide acetate suppresses pedophilic urges and arousability. Arch Sex Behav 34(6):691–705.
   PubMed Web of Science ®Google Scholar
• Schober JM, Byrne P, Kuhn PJ. 2006. Leuprolide acetate is a familiar drug that may modify sex-offender behaviour: the urologist’s role. BJU Int 97(4):684–686.
   PubMed Web of Science ®Google Scholar
• Seifert D, Moller-Mussavi S, Wirtz M. 2005. Risk assessment of sexual offenders in German forensic institutions. Int J Law Psychiatry 28(6):650–660.
   PubMed Web of Science ®Google Scholar
• Seto MC, Cantor JM, Blanchard R. 2006. Child pornography offenses are a valid diagnostic indicator of pedophilia. J Abnorm Psychol 115:610–615.
   PubMed Web of Science ®Google Scholar
• Shaw JA. 1999. Practice parameters for the assessment and treatment of children and adolescents who are sexually abusive of others. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry 38(S12):55–76.
   Google Scholar
• Shaw J, Applegate B, Rothe E. 1996. Psychopathology and personality disorders in adolescent sex offenders. Am J Forensic Psychiatry 17(4):19–37.
   Google Scholar
• Shekelle PG, Woolf SH, Eccles M, Grimshaw J. 1999. Developing guidelines. Br Med J 318:593–596.
   PubMed Web of Science ®Google Scholar
• Sherak DL. 2000. Pharmacological treatment of sexually offending behavior in people with mental retardation/developmental disabilities. Ment Health Asp Dev Disabil 3(2):62–74.
   Google Scholar
• Shiah IS, Chao CY, Mao WC, Chuang YJ. 2006. Treatment of paraphilic sexual disorder: the use of topiramate in fetishism. Int Clin Psychopharmacol 21:241–243.
   PubMed Web of Science ®Google Scholar
• Simpson G, Blaszczynski A, Hodgkinson A. 1999. Sex offending as a psychosocial sequela of traumatic brain injury. J Head Trauma Rehabil 14(6):567–580.
   PubMed Web of Science ®Google Scholar
• Smith JA Jr. 1986. Luteinizing hormone–releasing hormone (LH-RH) analogs in treatment of prostatic cancer. Urology 27:9–15.
   PubMed Web of Science ®Google Scholar
• Smith AD, Taylor PJ. 1999. Serious sex offending against women by men with schizophrenia: relationship of illness and psychotic symptoms to offending. Br J Psychiatry 174:233–237.
   PubMed Web of Science ®Google Scholar
• Soothill KL, Gibbens TCN. 1978. Recidivism of sexual offenders: reappraisal. Br J Criminol 18:267–275.
   Web of Science ®Google Scholar
• Southren AL, Gordon GG, Vittek J, Altman K. 1977. Effect of progestagens on androgen metabolism. Martini L, Motta M. Androgens and antiandrogens. New York: Raven Press. 263–279.
   Google Scholar
• Soyka M, Kranzler HR, Berglund M, Gorelick D, Hesselbrock V, Johnson BA, Möller HJ, the WFSBP Task Force on Treatment Guidelines for Substance Use Disorders. 2008. World J Biol Psychiatry 9 (1):6–23.
   PubMed Web of Science ®Google Scholar
• Stein DJ, Hollander E, Anthony DT, Schneier FR, Fallon BA, Liebowitz MR, Klein DF. 1992. Serotoninergic medications of sexual obsessions, sexual addictions, and paraphilias. J Clin Psychiatry 53(8):267–271.
   PubMed Web of Science ®Google Scholar
• Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ. 1989. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 69:523–590.
   PubMed Web of Science ®Google Scholar
• Sterkman P, Geerts F. 1966. Is benperidol (RF 504) the specific drug for the treatment of excessive and disinhibited sexual behaviour? Acta Neurol Psychiatr (Belgique) 66:1030–1040.
   Google Scholar
• Steward JT, Shin KJ. 1997. Paroxetine treatment of sexual disinhibition in dementia. Am J Psychiatry 154:1474.
   Web of Science ®Google Scholar
• Stewart JT. 2005. Optimizing antilibidinal treatment with medroxyprogesterone acetate. J Am Geriatr Soc 53 (2):359–360.
   PubMed Web of Science ®Google Scholar
• Stoléru S, Grégoire MC, Gérard D, Decety J, Lafarge E, Cinotti L, . 1999. Neuroanatomical correlates of visually evoked sexual arousal in human males. Arch Sex Behav 28(1):1–21.
   PubMed Web of Science ®Google Scholar
• Stoller RJ. 1975. Perversion: The erotic form of hatred. London: Karnac.
   Google Scholar
• Stone E, Thurston G. 1959. Castration for sexual offenders. Medico-Legal J 27:136–139.
   PubMedGoogle Scholar
• Stone TH, Winslade WJ, Klugman CM. 2000. Sex offenders, sentencing laws and pharmaceutical treatment: a prescription for failure. Behav Sci Law 18:83–110.
   PubMed Web of Science ®Google Scholar
• Sturup GK. 1972. Castration: the total treatment. Int Psychiatry Clin 8:175–195.
   Google Scholar
• Symmers WSC1968. Carcinoma of the breast in transsexual individuals after surgical and hormonal interference with primary and secondary sex characteristics Br Med J 2 (5597): 83–85.
   PubMedGoogle Scholar
• Tennent G, Bancroft J, Cass J. 1974. The control of deviant sexual behavior by drugs: a double-blind controlled study of benperidol, chlorpromazine, and placebo. Arch Sex Behav. 3 (3):261–71.
   PubMed Web of Science ®Google Scholar
• Tewksbury HC. 2003. A reader: sexual deviance. London: Lynne Rienner.
   Google Scholar
• Thibaut F. 2003. Perspectives on treatment interventions in paraphilias. Soares JC, Gershon S. The handbook of medical psychiatry. New York: Marcel Dekker. 909–918.
   Google Scholar
• Thibaut F, Kuhn JM, Colonna L. 1991. A possible antiagressive effect of cyproterone acetate. Br J Psychiatry 159:298–299.
   PubMed Web of Science ®Google Scholar
• Thibaut F, Cordier B, Kuhn JM. 1993. Effect of a long-lasting gonodatrophin hormone-releasing hormone agonist in six cases of severe male paraphilia. Acta Psychiatr Scand 87: 445–450.
   PubMed Web of Science ®Google Scholar
• Thibaut F, Cordier B, Kuhn J. 1996 Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: a lifetime treatment? Psychoneuroendocrinology 21(4):411–419.
   PubMed Web of Science ®Google Scholar
• Thibaut F, Kuhn JM, Cordier B, Petit M. 1998. Hormonal treatment of sex offenses.Encephale XXIV:132–137.
   Google Scholar
• Vance MA, Smith JA. 1984. Endocrine and clinical effects of leuprolide in prostate cancer. Clin Pharmacol Ther 36(3): 350–354.
   PubMed Web of Science ®Google Scholar
• Varela D, Black DW. 2002. Pedophilia treated with carbamazepine and clonazepam. Am J Psychiatry 159(7):1245–1246.
   PubMed Web of Science ®Google Scholar
• Wainberg M, Muench F, Morgenstern J, Hollander E, Irwin TW, Parsons JT, . 2006. A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. J Clin Psychiatry 67(12):1968–1973.
   PubMed Web of Science ®Google Scholar
• Ward N. 1975. Successful lithium treatment of transvestism associated with manic-depression. J Nerv Ment Dis 161: 204–206.
   PubMed Web of Science ®Google Scholar
• Ward T, Gannon TA, Birgden A. 2007. Human rights and the treatment of sex offenders. Sex Abuse 19:195–216.
   PubMed Web of Science ®Google Scholar
• Wawrose FE, Sisto TM. 1992. Clomipramine and a case of exhibitionism. Am J Psychiatry 149(6):843.
   PubMed Web of Science ®Google Scholar
• Weinberger LE, Sreenivasan S, Garrick T, Osran H. 2005. The impact of surgical castration on sexual recidivism risk among sexually violent predatory offenders. J Am Acad Psychiatry Law 33:16–36.
   PubMed Web of Science ®Google Scholar
• Weiner MF, Denke M, Williams K, Guzman R. 1992. Intramuscular medroxyprogesterone acetate for sexual aggression in elderly men. Lancet 339(8801):1121–1122.
   PubMed Web of Science ®Google Scholar
• White P, Bradley C, Ferriter M, Hatzipetrou L. 2000. Management for people with disorders of sexual preference and for convicted sexual offenders. Cochrane Database Syst Rev (2):CD000251.
   Google Scholar
• Whittaker LH. 1959. Estrogens and psychosexual disorders. Med J Aust 2:547–549.
   Google Scholar
• Wille R, Beier KM. 1989) Castration in Germany. Ann Sex Res 2:103–133.
   Google Scholar
• Wincze JP, Bansal S, Malamud M. 1986. Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation, and nocturnal penile tumescence in male sex offenders. Arch Sex Behav 15(4):293–305.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. 1992. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: WHO.
   Google Scholar
• Worling JR. 2001. Personality-based typology of adolescent male sexual offenders: differences in recidivism rates, victim-selection characteristics, and personal victimization histories. Sex Abuse 13(3):149–166.
   PubMedGoogle Scholar
• Worling JR, Curwen T. 2000. Adolescent sexual offender recidivism: success of specialized treatment and implications for risk prediction. Child Abuse Neglect 24(7):965–982.
   PubMed Web of Science ®Google Scholar
• Zbytovský J. 1993. Haloperidol decanoate (Janssen) in the treatment of sexual deviations. Cesk Psychiatr. 89(1):15–7.
   PubMedGoogle Scholar
• Zohar J, Kaplan Z, Benjamin J. 1994. Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study. J Clin Psychiatry 56(3):265–266.
   Google Scholar
• Zourkova A. 2000. Use of lithium and depot neuroleptics in the treatment of paraphilias. J Sex Marital Ther 26(4): 359–360.
   PubMed Web of Science ®Google Scholar
• Zourkova A. 2002. Psychotropic drugs in the treatment of paraphilic behaviour. Sci Med Fac Med Univ Brun Masarykianae 75(6):277–282.
   Google Scholar
• Zverina J, Zimanova J, Bartova D. 1991. Catamnesis of a group of 44 castrated sexual offenders. Cesk Psychiatr 87(1):28–34.
   PubMedGoogle Scholar